American Renal Associates (ARA) Rating Lowered to Market Perform at Leerink Swann
Leerink Swann cut shares of American Renal Associates (NYSE:ARA) to a market perform rating in a report released on Monday morning, The Fly reports.
A number of other research analysts also recently issued reports on the stock. Morgan Stanley initiated coverage on shares of American Renal Associates in a research report on Friday, December 14th. They issued an equal weight rating on the stock. ValuEngine downgraded shares of American Renal Associates from a hold rating to a sell rating in a research report on Monday, January 7th. Barclays started coverage on shares of American Renal Associates in a research report on Friday, December 14th. They set an equal weight rating and a $18.00 target price on the stock. SunTrust Banks reissued a buy rating and set a $16.00 target price on shares of American Renal Associates in a research report on Wednesday, January 9th. Finally, Deutsche Bank started coverage on shares of American Renal Associates in a research report on Thursday, January 3rd. They set a hold rating and a $12.00 target price on the stock. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $17.21.
Shares of American Renal Associates stock opened at $10.23 on Monday. The company has a current ratio of 1.03, a quick ratio of 1.00 and a debt-to-equity ratio of 5.48. American Renal Associates has a 52-week low of $9.20 and a 52-week high of $23.99. The company has a market capitalization of $314.44 million, a PE ratio of 16.77, a PEG ratio of 5.97 and a beta of 2.13.
About American Renal Associates
American Renal Associates Holdings, Inc operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease.
Further Reading: How Does the Quiet Period Work?
Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.